Eye-on-a-Chip Represents New Way to Do Disease Research

 Without some sort of testing platform, research on diseases and their treatments would grind to a halt

Written byUniversity of Pennsylvania
| 3 min read
Register for free to listen to this article
Listen with Speechify
0:00
3:00

A clump of cells in a Petri dish may have the same DNA as their counterparts in the body, but most of the similarities end there. Testing how they respond to new drugs, toxins, or environmental pollutants provides some insight into how cells might behave in the real world, but such tests can’t account for a myriad of factors that come along with the rich, three-dimensional environment they naturally exist within. Animal models provide a closer picture, but come with their own anatomical idiosyncrasies and ethical concerns.

These challenges, however, are preferable to the alternative: exposing humans to chemicals with unknown effects and risk. Without some sort of testing platform, research on diseases and their treatments would grind to a halt.

To continue reading this article, sign up for FREE to
Lab Manager Logo
Membership is FREE and provides you with instant access to eNewsletters, digital publications, article archives, and more.

CURRENT ISSUE - November/December 2025

AI & Automation

Preparing Your Lab for the Next Stage

Lab Manager Nov/Dec 2025 Cover Image